Vivid Dx raises $15M in seed financing to enhance pathogen detection and combat drug-resistant infections, led by Oxford Science Enterprises and Cedars-Sinai.
Amount Raised
$15 Million
Round Type
Seed
OxfordBiotechnologyHealth CareHealth DiagnosticsInvestors
Description
Vivid Dx has secured $15 million in seed financing to advance its precision diagnostics for drug-resistant infections. This funding, co-led by Oxford Science Enterprises and Cedars-Sinai Intellectual Property Co., aims to improve pathogen detection. The investment will support the company's efforts to enhance diagnostics that are critical in hospital settings. Additionally, Vivid Dx has appointed Keith O'Neill as CEO to lead its next phase of development.
Quick answer
Vivid Dx raised $15 Million in a Seed round, dated July 28, 2026. Investors: Jameel Investment Management Company, Oxford Science Enterprises and Cedars Sinai Intellectual Property Co. Vivid Dx is based in Oxford, England, United Kingdom.
- How much did Vivid Dx raise?
- Vivid Dx raised $15 Million in a Seed round on July 28, 2026.
- Who invested in Vivid Dx?
- Jameel Investment Management Company, Oxford Science Enterprises and Cedars Sinai Intellectual Property Co. are named as investors in this round.
- What does Vivid Dx do?
- Vivid Dx is a precision diagnostics company transforming pathogen detection and antimicrobial resistance testing.
- Where is Vivid Dx based and how big is it?
- Vivid Dx is based in Oxford, England, United Kingdom. Fundz records about 15 employees.
- Who are the decision-makers at Vivid Dx?
- Fundz holds 1 contact at Vivid Dx, including the Chief Operating & Product Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Biotechnology around the same time
Companies in the same sectors as Vivid Dx that raised within 45 days of this round, from Fundz verified event records.
- Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
- Cerenome, Inc. raised $3M (Post-IPO Equity) on September 10, 2026.
- OpZira raised $2M (Seed) on September 9, 2026.
- Anemo Labs raised $950K (Pre-Seed) on September 9, 2026.
- Hope Care raised $7M (Series A) on September 8, 2026.
- iPremom raised $17M (Seed) on September 2, 2026.
Who to call at Vivid Dx, and when
A new round usually means Vivid Dx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vivid Dx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vivid Dx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vivid Dx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vivid Dx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vivid Dx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.